随机对照试验的二次分析:方法论考虑和最佳实践
Qingyao Shang1, Shuna Yao2, Meishuo Ouyang3
1Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Annals of clinical epidemiology
|December 15, 2025
概括
随机对照试验 (RCT) 的二次分析有效地使用现有数据来获得新的临床见解. 最佳实践确保严格的标准和透明度,以推进基于证据的医学.
科学领域:
- 临床研究方法论 临床研究方法论
- 基于证据的医学基于证据的医学.
- 在医疗保健中的数据科学.
背景情况:
- 随机对照试验 (RCT) 的二次分析利用现有数据进行扩展研究.
- 这些分析对于最大限度地提高试验价值和解决超出最初范围的问题至关重要.
研究的目的:
- 概述RCT进行二次分析的方法考虑和最佳实践.
- 强调这些分析在推进基于证据的医学中的作用.
主要方法:
- 描述主要RCT数据来源和获取个人参与者数据的程序.
- 关键步骤包括研究问题制定,试验设计评估,数据处理,统计分析和临床解释.
- 讨论各种类型的二次分析:子组,生物标志物,健康经济学,方法论,不良事件和预测建模.
主要成果:
- 在二次分析中确定常见的挑战,包括数据适用性,缺失的数据,概括性问题和多重测试问题.
- 强调数据共享在促进科学发现方面日益重要.
- 强调在二次分析中需要严格的标准和透明度,以确保可靠的调查结果.
结论:
- 二次分析对于推动科学发现和为诊断和治疗模式提供信息至关重要.
- 遵守严格的标准和透明度对于这些分析的完整性和影响至关重要.
- 通过二次分析有效利用现有的RCT数据是现代基于证据的医学的基石.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
380
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
380
Randomized Experiments
8.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
8.8K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
204
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
204
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
162
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
162
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Blinding
3.8K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.8K


